| Literature DB >> 28851437 |
Anna Selva1,2,3, Ivan Solà4,5, Yuan Zhang6, Hector Pardo-Hernandez4,5, R Brian Haynes6,7, Laura Martínez García4, Tamara Navarro6, Holger Schünemann6, Pablo Alonso-Coello8,9,10.
Abstract
BACKGROUND: Identifying scientific literature addressing patients' views and preferences is complex due to the wide range of studies that can be informative and the poor indexing of this evidence. Given the lack of guidance we developed a search strategy to retrieve this type of evidence.Entities:
Keywords: Decision-making; Information storage and retrieval; Patient preference; Search engine; Terminology as topic
Mesh:
Year: 2017 PMID: 28851437 PMCID: PMC5576198 DOI: 10.1186/s12955-017-0698-5
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Measures capturing people’s views about healthcare outcomes
| Utility measures | Non-utility, quantitative measures | Qualitative findings | ||
|---|---|---|---|---|
| Direct techniques | Indirect techniques | Direct choice techniques | Interviews | Discussion groups |
| Standard gamble, time trade off, or visual analogue scales. | Pre-scored multi-attribute instruments [EQ-5D (euroQoL), the SF-6 health survey, or the health utility index (HUI-2 and HUI-3)] | Decision aids and direct choice studies. | Structured, semi-structured, unstructured, or in-depth. | Focus groups. |
Relative recall calculation
| Relative recall = |
Characteristics of the reference set of systematic reviews
| Systematic reviews | Topic | Techniques for elicitation of patient views and preferences of included studies |
|---|---|---|
| McLean 2012 [ | Antithrombotic therapy | Elicitation of health state utility values; Choices patients made when presented with decision aids; Interviews; Surveys. |
| Peasgood 2010 [ | Breast cancer | Elicitation of health state utility values. |
| Petrillo 2011 [ | COPD | Elicitation of health state utility values. |
| Bremmer 2007 [ | Prostate cancer | Elicitation of health state utility values. |
| Brooker 2013 [ | COPD | Choices patients made when presented with decision aids; Questionnaires, surveys; Structured and semi-structured interviews. |
| Morton 2010 [ | Chronic kidney disease | Qualitative research: focus groups, interviews |
Precision and Number Needed to Read (NNR)
| Precision: (number of relevant studies identified/total number of references retrieved from the search) X 100 |
Performance of the search strategy
| Systematic review | Topic areas | Studies included (n) | Studies indexed in Pubmed (n) | Studies retrieved by the search strategy n (%) | Patient preferences and decision making domain n (%) | Health state utility values domain n (%) |
|---|---|---|---|---|---|---|
| Initial test of the relative recall | ||||||
| McLean 2012 [ | Antithrombotic therapy | 50 | 49 (98%) | 48 (97.9) | 48 (97.9) | 3 (6.1) |
| Peasgood 2010 [ | Breast cancer | 50 | 44 (88%) | 36 (81.8) | 32 (72,73) | 34 (77,27) |
| Morton 2010 [ | Chronic kidney disease | 18 | 15 (83%) | 15 (100.0) | 15 (100.0) | 1 (6.7) |
| Petrillo 2011 [ | COPD | 11 | 11 (100%) | 10 (90.9) | 5 (45.4) | 9 (81.8) |
| Brooker 2013 [ | COPD | 12 | 12 (100%) | 11 (91.7) | 11(91.7) | 2 (16.7) |
| Bremmer 2007 [ | Prostate cancer | 21 | 20 (95%) | 19 (95.0) | 18(90.0) | 18 (90.0) |
| Relative recall results RR*(95% CI) (n) | 162 | 151 (93%) | 92% (86.4-95.4) (139) | 85.4% (78.9-90.1) (129) | 44.4% (36.4-52.3) (67) | |
| Re-test | ||||||
| Shaw 2016 [ | CV disease and daibetes | 14 | 13 (93%) | 11 (86,62) | 11 (86,62) | 0 (0.0) |
| Smith 2015 [ | Phyisical activity in joint replacement | 13 | 13 (100%) | 9 (69,23) | 9 (69,23) | 1 (7,69) |
| Finlayson 2015 [ | Metastatic cancer | 15 | 15 (100%) | 8 (53,3) | 8 (53,3) | 0 (0,0) |
| Köberich 2015 [ | Patient-centered nursing care | 12 | 12 (100%) | 11 (91,6) | 11 (91,6) | 0 (0,0) |
| Loewen 2017 [ | Antithrombotic therapy in atrial fibr. | 28 | 26 (93%) | 25 (96,15) | 25 (96,15) | 11 (42,3) |
| Cowley 2016 [ | Esophagogastric cancer | 2 | 2 (100%) | 0 (0) | 0 (0) | 0 (0) |
| Brown 2017 [ | Lung cancer | 27 | 27 (100%) | 23 (85,15) | 11 (40,74) | 20(74,07) |
| Jeong 2016 [ | Colorectal cancer | 57 | 56 (98%) | 53 (94,64) | 26 (46,42) | 51 (91,07) |
| Carter 2015 [ | Gastric cancer | 8 | 7 (87.5%) | 7 (100) | 3 (42,8) | 7 (100) |
| Ward 2017 [ | Brain trauma | 5 | 5 (100%) | 4 (80) | 4 (80) | 2 (40) |
| Relative recall results RR*(95% CI) (n) | 181 | 176 (97%) | 85,8% (79.9-90.2) (151) | 61.4 (54.0-68.3) (108) | 52.3% (44.9-59.5) (92) | |
| Total. Relative recall results RR*(95% CI) (n) | 343 | 327 (95%) | 88,7% (84.8-91.7) (290) | 72.5% (67.4-77.0) (237) | 48.6% (43.2-54.0) (159) | |
*RR: Relative Recall
Use of the search in the development of a systematic review on COPD
| COPD systematic reviewa | Retrieved references (n) | Relevant references (n) | Relevant studies on non-utility measures | Relevant studies on utiltiy measures | Relevant qualitative research | Precision (%) 95% CI | NNR |
|---|---|---|---|---|---|---|---|
| Global search strategy | 12,574 | 252 | 93 | 66 | 110 | 2.0 (1.77-2.26) | 49.8 |
| Patient preferences domain | 11,789 | 203 | 87 | 23 | 93 | 1.52 (1.32-1.76)b | 65.5b |
| Utility values domain | 1008 | 70 | 11 | 59 | 2 | 5.85 (4.56-8.08)c | 17.1c |
aSearch period: from inception until 01/01/2015
bThe precision for the patient preferences domain is calculated as: (number of non-utility studies + qualitative studies)/number of retrieved references by the patient preferences domain. The NNR is calculated as: number of retrieved references by the patient preferences domain/(number of non-utility studies + qualitative studies)
cThe precision for the utility values domain is calculated as: number of studies on utility measures/number of retrieved references by the utility values domain. The NNR is calculated as: number of retrieved references by utility values domain/number of studies on utility measures
Use of the search strategy in the development of a healthcare guideline
| Allergic rhinitis in asthma guidelinea | Retrieved references (n) | Relevant references (n) | Relevant studies on non-utility measures | Relevant studies on utiltiy measures | Relevant qualitative research | Precision (%) 95% CI | NNR |
|---|---|---|---|---|---|---|---|
| Global search strategy | 1560 | 33 | 27 | 6 | 0 | 2,12 (1.51-2.96) | 47,27 |
| Patient preferences domain | 1487 | 31 | 27 | 4 | 0 | 1,82b (1.25-2.63) | 55,07b |
| Utility values domain | 92 | 7 | 1 | 6 | 0 | 6,52c (3.02-13.51) | 15,33c |
aSearch period: from inception until May 1st 2015
bThe precision for the patient preferences domain is calculated as: (number of non-utility studies + qualitative studies)/number of retrieved references by patient preferences domain. The NNR is calculated as: number of retrieved references by patient preferences domain/(number of non-utility studies + qualitative studies)
cThe precision the utility values domain is calculated as: number of studies on utility measures/number of retrieved references by utility values domain. The NNR is calculated as: number of retrieved references by utility values domain/number of studies on utility measures
Use of the the search strategy in the update of a healthcare guideline
| Care during pregnancy and puerperium guidelinea | Retrieved references (n) | Relevant references (n) | Relevant studies on non-utility measures | Relevant studies on utility measures | Relevant Qualitative research | Precision (%) 95% CI | NNR |
|---|---|---|---|---|---|---|---|
| Global search strategy | 668 | 19 | 9 | 1 | 9 | 2.84 (1.83-4.40) | 35.2 |
| Patient preferences domain | 653 | 19 | 9 | 1 | 9 | 2.76b (1.75-4.31) | 36.3b |
| Utility values domain | 22 | 2 | 2 | 0 | 0 | 0 | NA |
aSearch period: First cycle from 01/01/2012- 31/08/2014; Second cycle from 01/09/2014 to 28/02/2015; Third cycle from 01/03/2015 to 31/08/2015
bThe precision for the patient preferences domain is calculated as: (number of non-utility studies + qualitative studies)/number of retrieved references by patient preferences domain. The NNR is calculated as: number of retrieved references by patient preferences domain/(number of non-utility studies + qualitative studies)